{"id":"https://openalex.org/W1964794866","doi":"https://doi.org/10.1097/00007691-200204000-00001","title":"Toxicologic Aspects of Heroin Substitution Treatment","display_name":"Toxicologic Aspects of Heroin Substitution Treatment","publication_year":2002,"publication_date":"2002-04-01","ids":{"openalex":"https://openalex.org/W1964794866","doi":"https://doi.org/10.1097/00007691-200204000-00001","mag":"1964794866","pmid":"https://pubmed.ncbi.nlm.nih.gov/11897965"},"language":"en","primary_location":{"id":"doi:10.1097/00007691-200204000-00001","doi":"https://doi.org/10.1097/00007691-200204000-00001","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00007691-200204000-00001","pdf_url":null,"source":{"id":"https://openalex.org/S179268941","display_name":"Therapeutic Drug Monitoring","issn_l":"0163-4356","issn":["0163-4356","1536-3694"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Drug Monitoring","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110819058","display_name":"Edward J. Cone","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Edward J. Cone","raw_affiliation_strings":["ConeChem Research, Baltimore, Maryland, USA","ConeChem Research, Baltimore, Maryland, and \u2020National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ConeChem Research, Baltimore, Maryland, USA","institution_ids":[]},{"raw_affiliation_string":"ConeChem Research, Baltimore, Maryland, and \u2020National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060972692","display_name":"Kenzie L. Preston","orcid":"https://orcid.org/0000-0003-0603-2479","observed_orcids":["https://orcid.org/0000-0003-0603-2479"]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenzie L. Preston","raw_affiliation_strings":["and reprint requests to Kenzie L. Preston, Ph.D., NIDA Intramural Research Program, 5500 Nathan Shock Drive, Baltimore, MD 21224; E-mail: [email\u00a0protected]","E-mail: [email\u00a0protected]","reprint requests to Kenzie L. Preston, Ph.D., NIDA Intramural Research Program, 5500 Nathan Shock Drive, Baltimore, MD 21224"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"and reprint requests to Kenzie L. Preston, Ph.D., NIDA Intramural Research Program, 5500 Nathan Shock Drive, Baltimore, MD 21224; E-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I1327069482"]},{"raw_affiliation_string":"E-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"reprint requests to Kenzie L. Preston, Ph.D., NIDA Intramural Research Program, 5500 Nathan Shock Drive, Baltimore, MD 21224","institution_ids":["https://openalex.org/I1327069482"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5110819058"],"corresponding_institution_ids":["https://openalex.org/I1327069482"],"apc_list":null,"apc_paid":null,"fwci":0.7649,"has_fulltext":false,"cited_by_count":27,"citation_normalized_percentile":{"value":0.5,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"24","issue":"2","first_page":"193","last_page":"198"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.023000000044703484,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/methadone","display_name":"methadone","score":0.8429999947547913},{"id":"https://openalex.org/keywords/buprenorphine","display_name":"buprenorphine","score":1.0},{"id":"https://openalex.org/keywords/drug-testing","display_name":"drug testing","score":0.625},{"id":"https://openalex.org/keywords/urine-drug-testing","display_name":"urine drug testing","score":0.7070000171661377},{"id":"https://openalex.org/keywords/sweat-test","display_name":"sweat test","score":0.6259999871253967},{"id":"https://openalex.org/keywords/hair-analysis","display_name":"hair analysis","score":0.8130000233650208},{"id":"https://openalex.org/keywords/oral-fluid-testing","display_name":"oral fluid testing","score":0.949999988079071},{"id":"https://openalex.org/keywords/opioid-agonists","display_name":"opioid agonists","score":0.5680000185966492}],"concepts":[{"id":"https://openalex.org/C2778903686","wikidata":"https://www.wikidata.org/wiki/Q60168","display_name":"Heroin","level":3,"score":0.9161877036094666},{"id":"https://openalex.org/C2778767360","wikidata":"https://www.wikidata.org/wiki/Q179996","display_name":"Methadone","level":2,"score":0.8315272331237793},{"id":"https://openalex.org/C2778949969","wikidata":"https://www.wikidata.org/wiki/Q407721","display_name":"Buprenorphine","level":4,"score":0.6094735264778137},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5848554968833923},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5730534195899963},{"id":"https://openalex.org/C2779225474","wikidata":"https://www.wikidata.org/wiki/Q842424","display_name":"Urinalysis","level":3,"score":0.5177289843559265},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.504074215888977},{"id":"https://openalex.org/C40010229","wikidata":"https://www.wikidata.org/wiki/Q3184856","display_name":"Substance abuse","level":2,"score":0.44305017590522766},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4231888949871063},{"id":"https://openalex.org/C2780026642","wikidata":"https://www.wikidata.org/wiki/Q40924","display_name":"Urine","level":2,"score":0.3082382380962372},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2647385597229004},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.16185173392295837},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.11605864763259888},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D006197","descriptor_name":"Hair","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006556","descriptor_name":"Heroin Dependence","qualifier_ui":"Q000534","qualifier_name":"rehabilitation","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008691","descriptor_name":"Methadone","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D008691","descriptor_name":"Methadone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008691","descriptor_name":"Methadone","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D008691","descriptor_name":"Methadone","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D008692","descriptor_name":"Methadyl Acetate","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D008692","descriptor_name":"Methadyl Acetate","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008692","descriptor_name":"Methadyl Acetate","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D008692","descriptor_name":"Methadyl Acetate","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D009294","descriptor_name":"Narcotics","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D009294","descriptor_name":"Narcotics","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009294","descriptor_name":"Narcotics","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D009294","descriptor_name":"Narcotics","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D012463","descriptor_name":"Saliva","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013542","descriptor_name":"Sweat","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00007691-200204000-00001","doi":"https://doi.org/10.1097/00007691-200204000-00001","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00007691-200204000-00001","pdf_url":null,"source":{"id":"https://openalex.org/S179268941","display_name":"Therapeutic Drug Monitoring","issn_l":"0163-4356","issn":["0163-4356","1536-3694"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Drug Monitoring","raw_type":"journal-article"},{"id":"pmid:11897965","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11897965","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic drug monitoring","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W147717426","https://openalex.org/W1189795309","https://openalex.org/W1965003010","https://openalex.org/W1966282663","https://openalex.org/W1977264881","https://openalex.org/W1977378880","https://openalex.org/W1979184030","https://openalex.org/W1979600943","https://openalex.org/W1986288731","https://openalex.org/W1992389336","https://openalex.org/W1996109234","https://openalex.org/W2018960901","https://openalex.org/W2020454958","https://openalex.org/W2024099636","https://openalex.org/W2026569186","https://openalex.org/W2029906878","https://openalex.org/W2032916190","https://openalex.org/W2044313277","https://openalex.org/W2050443628","https://openalex.org/W2052075114","https://openalex.org/W2055225606","https://openalex.org/W2058324328","https://openalex.org/W2062082903","https://openalex.org/W2062971972","https://openalex.org/W2063539450","https://openalex.org/W2066784402","https://openalex.org/W2067594932","https://openalex.org/W2073902466","https://openalex.org/W2076245281","https://openalex.org/W2097145370","https://openalex.org/W2107555396","https://openalex.org/W2114718584","https://openalex.org/W2133801459","https://openalex.org/W2144525027","https://openalex.org/W2149015710","https://openalex.org/W2150622631","https://openalex.org/W2229912395","https://openalex.org/W2250136567","https://openalex.org/W2328808355","https://openalex.org/W2410735391","https://openalex.org/W2415521683","https://openalex.org/W4236903699"],"related_works":["https://openalex.org/W1986969488","https://openalex.org/W4395054731","https://openalex.org/W2054117065","https://openalex.org/W2108625905","https://openalex.org/W4248816812","https://openalex.org/W2731713951","https://openalex.org/W2811238595","https://openalex.org/W2032054246","https://openalex.org/W2002326633","https://openalex.org/W61945266"],"abstract_inverted_index":{"Heroin":[0],"abuse":[1,123],"is":[2,43],"an":[3,21],"international":[4],"problem":[5],"with":[6,190],"which":[7],"all":[8],"countries":[9,14],"must":[10],"continually":[11],"cope.":[12],"Many":[13],"have":[15,113,155,176],"implemented":[16],"heroin":[17,27,50,122,128,209],"substitution":[18,210],"therapy":[19],"as":[20],"effective":[22,203],"means":[23,204],"of":[24,78,86,160,164],"decreasing":[25],"illicit":[26,130],"use,":[28],"crime,":[29],"HIV":[30],"risk,":[31],"and":[32,34,38,62,124,149,152,174,187,212],"death,":[33],"in":[35,54,72,137,145,166,170,181,198,208,217],"improving":[36],"employment":[37],"social":[39],"adjustment.":[40],"Although":[41],"methadone":[42,136,165],"the":[44,161,194],"most":[45],"commonly":[46],"used":[47],"medication":[48],"for":[49,97,107,125,135,143,158,179],"substitution,":[51],"other":[52],"agonists":[53],"current":[55],"use":[56,144,180],"include":[57],"levomethadyl":[58],"acetate":[59],"(LAAM),":[60],"buprenorphine,":[61],"pharmaceutical-grade":[63,127],"heroin.":[64,131],"This":[65],"report":[66],"reviews":[67],"toxicologic":[68],"issues":[69],"that":[70,83],"arise":[71],"these":[73],"programs.":[74],"A":[75],"broad":[76],"array":[77],"testing":[79,88,199],"methodologies":[80],"are":[81],"available":[82],"allow":[84],"selection":[85],"on-site":[87],"or":[89,103],"laboratory-based":[90],"methodology.":[91],"Urine":[92],"specimens":[93],"may":[94],"be":[95,141],"monitored":[96],"nonprescribed":[98],"drugs":[99],"on":[100],"a":[101],"qualitative":[102],"semiquantitative":[104],"basis.":[105],"Methods":[106],"differentiating":[108],"opiate":[109],"sources":[110],"by":[111],"urinalysis":[112],"been":[114,156,177],"proposed":[115],"to":[116,140,172,205,215],"distinguish":[117],"poppy":[118],"seed":[119],"consumption":[120],"from":[121,129],"distinguishing":[126],"Therapeutic":[132],"drug":[133,182],"monitoring":[134],"plasma":[138,173],"continues":[139],"evaluated":[142,178],"establishing":[146],"adequate":[147],"dosing":[148],"detecting":[150],"diversion,":[151],"new":[153],"methods":[154],"devised":[157],"measurement":[159],"optical":[162],"isomers":[163],"plasma.":[167],"Biologic":[168],"specimens,":[169],"addition":[171],"urine,":[175],"monitoring,":[183],"including":[184],"sweat,":[185],"hair,":[186],"oral":[188],"fluid,":[189],"promising":[191],"results.":[192],"Overall,":[193],"many":[195],"recent":[196],"developments":[197],"methodology":[200],"provide":[201],"more":[202],"assess":[206],"patients":[207],"programs":[211],"should":[213],"contribute":[214],"improvements":[216],"public":[218],"health.":[219]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}